Managing semaglutide risks means knowing its side effects and how it interacts with other drugs
If you have questions about which medication is right for you, Dr
Can side effects differ between the two
Methods: 25 women with PCOS and obesity, aged 33.7 5.3 years (mean SD), were treated with once-weekly subcutaneous semaglutide 1.0 mg as an adjunct to metformin 2000 mg/day and lifestyle intervention for 16 weeks
Importantly, the pivotal cardiovascular and obesity outcome trials of GLP-1RAs, including the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN), Semaglutide Treatment Effect in People with obesity (STEP), and SURPASS (tirzepatide) programs, did not report clinically meaningful increases in AITD or sustained thyroid dysfunction [7,8,30]